Physician

William S Przybysz, MD

According to 2025 Medicare claims, William Przybysz, MD (NPI: 1386064723) practices family practice in the Wheeling, WV-OH market, with the plurality of this provider's patient population coming from Ohio, WV. This provider's primary affiliated billing organization is WHEELING HOSPITAL INC (NPI: 1548923923; TIN: 55-0357057) and primary practice location at 26003-6379. Przybysz is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Przybysz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 339 traditional Medicare patients, billed 1,090 HCPCS/CPT codes, and received $65,143 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 6,005 prescription claims across 471 beneficiaries totaling $688,337 in drug costs, led by Jardiance (Empagliflozin). DME data shows 145 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $41,596 to $688,337. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,945 to $15,509.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	149	290	$16,612
2018	247	925	$53,878
2019	323	1,153	$70,871
2020	274	1,431	$69,674
2021	298	1,083	$68,339
2022	271	719	$50,117
2023	311	830	$59,078
2024	339	1,090	$65,143

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	80	601	$41,596
2016	250	1,849	$102,592
2017	296	4,659	$255,641
2018	307	6,084	$506,213
2019	342	6,571	$536,491
2020	371	6,996	$612,448
2021	385	6,994	$711,565
2022	396	5,054	$519,957
2023	424	4,411	$485,186
2024	471	6,005	$688,337

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$1,560
2016	N/R	20	$1,587
2017	N/R	107	$3,508
2018	15	137	$2,909
2019	30	172	$3,704
2020	13	194	$6,236
2021	N/R	122	$5,023
2022	15	170	$6,506
2023	N/R	202	$11,007
2024	11	145	$11,796

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	135	135	$120
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	59	145	$58
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	212	379	$56
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	64	69	$38
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	122	162	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	69	4,355	$85,472
Januvia	Sitagliptin Phosphate	62	4,432	$79,971
Mounjaro	Tirzepatide	43	1,484	$54,589
Eliquis	Apixaban	54	2,758	$52,082
Ozempic	Semaglutide	52	1,624	$49,618

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	26	$6,974
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	57	$3,975
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	38	$591
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	24	$257

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for William S. Przybysz, MD?

Tedicare shows public-source Medicare data for William S. Przybysz, MD (NPI 1386064723), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William S. Przybysz, MD have ACO affiliation data?

William S. Przybysz, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to William S. Przybysz, MD?

William S. Przybysz, MD is linked to WHEELING HOSPITAL INC (billing NPI 1548923923) in the available physician profile data.

Does William S. Przybysz, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.